Treating HCV infection has never been cheap, but it just got a lot more expensive. Dr. M. Brian Fennerty addresses the reality for practitioners in the latest
Gut Check.
Newly available drugs for treating hepatitis C virus infection represent major improvements in effectiveness and tolerability but can cost $80,000. Given their high price tags, how are these latest regimens being used, and who is paying (or not paying) for them? Dr. M. Brian Fennerty polls the field on this issue at Gut Check.